Post-COVID Biopharma Regulatory Reactions

Source: Bioprocess Online

Regulatory interactions changed significantly in the midst of the COVID-19 pandemic, and some of those changes are sure to stick. In this segment of the BioProcess Online Live! event Manufacturing Vaccines On COVID's Coattails, Valneva Chief Medical Officer Dr. Juan Carlos Jaramillo, vaccine commercialization expert Kimberly Murphy, and Christina Yi, Chief Operating Officer at Vaxxinity share their experiences working with FDA, EMA, MHRA, and others in "COVID Time." Listen in as they share their experiences and best practices learned as they work with specific global regulatory bodies while trying to expedite time to market.

View the full presentation on-demand here.